Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Charles DeBattista

Showing results (1-10 of 71) with videos related to

Pageof 8
Sort By:
Journal of Psychopharmacology (Oxford, England)|April 29, 2006
Augmentation and combination strategies for depressionCharles DeBattista
Expert Review of Neurotherapeutics|April 28, 2005
Executive dysfunction in major depressive disorderCharles DeBattista
Current Drug Safety|April 17, 2010
Safety considerations of the use of second generation antipsychotics in the treatment of major depression: extrapyramidal and metabolic side effectsCharles DeBattista, Kristina DeBattista
Current Psychiatry Reports|December 2, 2005
Update on augmentation of antidepressant response in resistant depressionCharles DeBattista, Anna Lembke
CNS Drugs|May 21, 2009
Utility of atypical antipsychotics in the treatment of resistant unipolar depressionCharles DeBattista, Jessica Hawkins
Current Alzheimer Research|June 25, 2005
C-1073 (mifepristone) in the adjunctive treatment of Alzheimer's diseaseCharles DeBattista, Joseph Belanoff
Trends in Endocrinology and Metabolism: TEM|March 15, 2006
The use of mifepristone in the treatment of neuropsychiatric disordersCharles DeBattista, Joseph Belanoff
Psychopharmacology Bulletin|July 12, 2024
The Black Book of Psychotropic Dosing and MonitoringCharles DeBattista, Alan F Schatzberg
Neuropsychiatric Disease and Treatment|March 21, 2009
Depression and smoking cessation: does the evidence support psychiatric practice?Anna Lembke, Kenasha Johnson, Charles DeBattista
The Journal of Clinical Psychiatry|January 27, 2005
A multicenter, placebo-controlled study of modafinil augmentation in partial responders to selective serotonin reuptake inhibitors with persistent fatigue and sleepinessMaurizio Fava, Michael E Thase, Charles DeBattista
Pageof 8

Showing results (1-10 of 71) with videos related to

Sort By:
Pageof 8
Journal of Psychopharmacology (Oxford, England)|April 29, 2006
Augmentation and combination strategies for depressionCharles DeBattista
Expert Review of Neurotherapeutics|April 28, 2005
Executive dysfunction in major depressive disorderCharles DeBattista
Current Drug Safety|April 17, 2010
Safety considerations of the use of second generation antipsychotics in the treatment of major depression: extrapyramidal and metabolic side effectsCharles DeBattista, Kristina DeBattista
Current Psychiatry Reports|December 2, 2005
Update on augmentation of antidepressant response in resistant depressionCharles DeBattista, Anna Lembke
CNS Drugs|May 21, 2009
Utility of atypical antipsychotics in the treatment of resistant unipolar depressionCharles DeBattista, Jessica Hawkins
Current Alzheimer Research|June 25, 2005
C-1073 (mifepristone) in the adjunctive treatment of Alzheimer's diseaseCharles DeBattista, Joseph Belanoff
Trends in Endocrinology and Metabolism: TEM|March 15, 2006
The use of mifepristone in the treatment of neuropsychiatric disordersCharles DeBattista, Joseph Belanoff
Psychopharmacology Bulletin|July 12, 2024
The Black Book of Psychotropic Dosing and MonitoringCharles DeBattista, Alan F Schatzberg
Neuropsychiatric Disease and Treatment|March 21, 2009
Depression and smoking cessation: does the evidence support psychiatric practice?Anna Lembke, Kenasha Johnson, Charles DeBattista
The Journal of Clinical Psychiatry|January 27, 2005
A multicenter, placebo-controlled study of modafinil augmentation in partial responders to selective serotonin reuptake inhibitors with persistent fatigue and sleepinessMaurizio Fava, Michael E Thase, Charles DeBattista
Pageof 8